The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Prognostic factor of nivolumab for advanced gastric cancer patients with poor performance status patients.
 
Toshihiko Matsumoto
Honoraria - Chugai Pharma; Chugai Pharma; Chugai Pharma; Chugai Pharma; Lilly Japan; Lilly Japan; Lilly Japan; Lilly Japan; Merck Serono; Merck Serono; Merck Serono; Merck Serono; Ono Pharmaceutical; Ono Pharmaceutical; Ono Pharmaceutical; Ono Pharmaceutical; Sanofi; Sanofi; Sanofi; Sanofi; Taiho Pharmaceutical; Taiho Pharmaceutical; Taiho Pharmaceutical; Taiho Pharmaceutical
 
Ukyo Okazaki
No Relationships to Disclose
 
Yusuke Kurioka
No Relationships to Disclose
 
Shogo Kimura
No Relationships to Disclose
 
Takao Tsuzuki
No Relationships to Disclose
 
Shinjiro Takagi
No Relationships to Disclose
 
Masahiro Takatani
No Relationships to Disclose
 
Hirofumi Morishita
No Relationships to Disclose